Sign in
LAB Stock Price, Chart, Stats & News
Standard Biotools Inc
Save
Standard Biotools Inc (LAB) does not currently pay a dividend.
321.16M
Market cap
–
Current P/E
–
Forward P/E
LAB chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 49.86% |
Operating margin | -109.34% |
Pretax margin | -113.33% |
Net margin | -87.77% |
Effective tax rate | 39.17% |
ROA | -13.19% |
ROE | -17.59% |
D/E | 0.07x |
Interest coverage ratio | -3588.65x |
LAB valuation
P/E | – |
P/S | 4.10x |
P/B | 0.81x |
P/CF | -4.65x |
P/FCF | -4.23x |
P/OCF | -4.65x |
PEG | -0.11x |
EV multiple | -5.11x |
About
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses.
Similar securities
Based on sector and market capitalization
Report issue